Author: Seer, Inc.

Posted Date:

April 13, 2026

Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

Seer, Inc.

April 13, 2026
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Seer, Inc.

April 9, 2026
Patent Board Upholds Seer’s Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

Seer, Inc.

March 30, 2026
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

Seer, Inc.

February 26, 2026
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Seer, Inc.

February 26, 2026
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

Seer, Inc.

February 19, 2026
Seer to Participate in the TD Cowen 46th Annual Health Care Conference

Seer, Inc.

February 18, 2026
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Seer, Inc.

February 8, 2026